Every Form 483 and Warning Letter issued by the FDA is a cautionary tale. In this webinar two experts will outline the practices, processes and regulations governing calibration in GxP-regulated applications. We will analyze several calibration-related Form 483s and Warning Letters issued over the last few years in a range of regulated industries, including pharmaceuticals, medical devices, nutraceuticals, medical devices and cosmetics. To err is human; failure to calibrate properly can result in enforcement action.
This webinar provides practical lessons on how to meet FDA calibration requirements and avoid the costs of dealing with such actions. Join our free webinar!
